Osanto

Vaccine Trials for the Clinician: Prospects for Tumor Antigens.

S. Osanto, Osanto, 1997, The Oncologist.

Th 1 / Th 2 Lymphocytes + Tumor-Associated Antigen CAMEL by CD 4 HLA-DR-Restricted Epitopes of the Identification of Multiple

Susanne, M. Griffioen, Osanto, 2004 .